+关注
yvoyvo111
暂无个人介绍
IP属地：未知
5
关注
1
粉丝
0
主题
0
勋章
主贴
热门
yvoyvo111
2021-07-15
Interesting
Hong Kong biotech start-up is set to list on the Nasdaq in a SPAC merger
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3586436690635790","uuid":"3586436690635790","gmtCreate":1623342666186,"gmtModify":1639015825638,"name":"yvoyvo111","pinyin":"yvoyvo111","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/a74d85d082b03207ea6d7dbf3a59dd5d","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":5,"tweetSize":1,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":147851809,"gmtCreate":1626352199601,"gmtModify":1633927626176,"author":{"id":"3586436690635790","authorId":"3586436690635790","name":"yvoyvo111","avatar":"https://static.tigerbbs.com/a74d85d082b03207ea6d7dbf3a59dd5d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586436690635790","authorIdStr":"3586436690635790"},"themes":[],"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/147851809","repostId":"1141652676","repostType":4,"repost":{"id":"1141652676","kind":"news","pubTimestamp":1626342364,"share":"https://www.laohu8.com/m/news/1141652676?lang=&edition=full","pubTime":"2021-07-15 17:46","market":"us","language":"en","title":"Hong Kong biotech start-up is set to list on the Nasdaq in a SPAC merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1141652676","media":"CNBC","summary":"Hong Kong biotech company Prenetics is set to merge with Artisan Acquisition, a special purpose acqu","content":"<div>\n<p>Hong Kong biotech company Prenetics is set to merge with Artisan Acquisition, a special purpose acquisition company backed by Hong Kong billionaire Adrian Cheng, according to a source close to the ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/15/hong-kong-biotech-prenetics-to-list-on-the-nasdaq-in-a-spac-merger.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong biotech start-up is set to list on the Nasdaq in a SPAC merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong biotech start-up is set to list on the Nasdaq in a SPAC merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-15 17:46 GMT+8 <a href=https://www.cnbc.com/2021/07/15/hong-kong-biotech-prenetics-to-list-on-the-nasdaq-in-a-spac-merger.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Hong Kong biotech company Prenetics is set to merge with Artisan Acquisition, a special purpose acquisition company backed by Hong Kong billionaire Adrian Cheng, according to a source close to the ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/15/hong-kong-biotech-prenetics-to-list-on-the-nasdaq-in-a-spac-merger.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.cnbc.com/2021/07/15/hong-kong-biotech-prenetics-to-list-on-the-nasdaq-in-a-spac-merger.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141652676","content_text":"Hong Kong biotech company Prenetics is set to merge with Artisan Acquisition, a special purpose acquisition company backed by Hong Kong billionaire Adrian Cheng, according to a source close to the deal.\nThe SPAC is already traded on the Nasdaq under the ticker ARTA.\nSPACs are shell companies set up to raise money through an initial public offering — their sole purpose is to merge with or acquire an existing private company and to take it public. They bypass Wall Street's traditional IPO process.\nPrenetics is a diagnostic and genetic testing company with significant operations in Hong Kong and the U.K. It was founded by serial entrepreneur Danny Yeung and will become the first billion-dollar start-up in Hong Kong to exit its unicorn status.\nA technician handles a sample at a Prenetics laboratory in Hong Kong, China, on Jan. 26, 2018.Anthony Kwan | Bloomberg | Getty Images\nThe transaction is expected to close by the end of this year. UBS, Citi, Credit Suisse and CICC are financial advisors on the potential de-SPAC transaction.\nArtisan raised $339 million in the SPAC, and has signed a further $60 million forward purchase agreements with investment firm Aspex and PAG, a private asset manager for institutional investors, according to the source who requested anonymity as that person was not allowed to discuss the information publicly.\nTalks with additional pipe investors are said to be ongoing, with strong initial demand, the source said.\nThe company has grown significantly since its founding in 2014 with projected revenue in 2021 is expected to be more than $200 million, marking 400% growth on year, according to the source.\nAnnual revenue is expected to reach $600 million by 2025, said the source.","news_type":1},"isVote":1,"tweetType":1,"viewCount":264,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":147851809,"gmtCreate":1626352199601,"gmtModify":1633927626176,"author":{"id":"3586436690635790","authorId":"3586436690635790","name":"yvoyvo111","avatar":"https://static.tigerbbs.com/a74d85d082b03207ea6d7dbf3a59dd5d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586436690635790","idStr":"3586436690635790"},"themes":[],"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/147851809","repostId":"1141652676","repostType":4,"repost":{"id":"1141652676","kind":"news","pubTimestamp":1626342364,"share":"https://www.laohu8.com/m/news/1141652676?lang=&edition=full","pubTime":"2021-07-15 17:46","market":"us","language":"en","title":"Hong Kong biotech start-up is set to list on the Nasdaq in a SPAC merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1141652676","media":"CNBC","summary":"Hong Kong biotech company Prenetics is set to merge with Artisan Acquisition, a special purpose acqu","content":"<div>\n<p>Hong Kong biotech company Prenetics is set to merge with Artisan Acquisition, a special purpose acquisition company backed by Hong Kong billionaire Adrian Cheng, according to a source close to the ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/15/hong-kong-biotech-prenetics-to-list-on-the-nasdaq-in-a-spac-merger.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong biotech start-up is set to list on the Nasdaq in a SPAC merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong biotech start-up is set to list on the Nasdaq in a SPAC merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-15 17:46 GMT+8 <a href=https://www.cnbc.com/2021/07/15/hong-kong-biotech-prenetics-to-list-on-the-nasdaq-in-a-spac-merger.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Hong Kong biotech company Prenetics is set to merge with Artisan Acquisition, a special purpose acquisition company backed by Hong Kong billionaire Adrian Cheng, according to a source close to the ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/15/hong-kong-biotech-prenetics-to-list-on-the-nasdaq-in-a-spac-merger.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.cnbc.com/2021/07/15/hong-kong-biotech-prenetics-to-list-on-the-nasdaq-in-a-spac-merger.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141652676","content_text":"Hong Kong biotech company Prenetics is set to merge with Artisan Acquisition, a special purpose acquisition company backed by Hong Kong billionaire Adrian Cheng, according to a source close to the deal.\nThe SPAC is already traded on the Nasdaq under the ticker ARTA.\nSPACs are shell companies set up to raise money through an initial public offering — their sole purpose is to merge with or acquire an existing private company and to take it public. They bypass Wall Street's traditional IPO process.\nPrenetics is a diagnostic and genetic testing company with significant operations in Hong Kong and the U.K. It was founded by serial entrepreneur Danny Yeung and will become the first billion-dollar start-up in Hong Kong to exit its unicorn status.\nA technician handles a sample at a Prenetics laboratory in Hong Kong, China, on Jan. 26, 2018.Anthony Kwan | Bloomberg | Getty Images\nThe transaction is expected to close by the end of this year. UBS, Citi, Credit Suisse and CICC are financial advisors on the potential de-SPAC transaction.\nArtisan raised $339 million in the SPAC, and has signed a further $60 million forward purchase agreements with investment firm Aspex and PAG, a private asset manager for institutional investors, according to the source who requested anonymity as that person was not allowed to discuss the information publicly.\nTalks with additional pipe investors are said to be ongoing, with strong initial demand, the source said.\nThe company has grown significantly since its founding in 2014 with projected revenue in 2021 is expected to be more than $200 million, marking 400% growth on year, according to the source.\nAnnual revenue is expected to reach $600 million by 2025, said the source.","news_type":1},"isVote":1,"tweetType":1,"viewCount":264,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
